PDCD1 and neoplasm: reported that following chemoradiotherapy, the frequency of inhibitory receptors, including PD-1 and TIGIT, on tumor-infiltrating CD8+ T cells was markedly reduced, while PD-L1 expression on circulating CD8+ T cells was increased (92).